Skip to main content
OpenTrials
Completed

NCT Number: NCT04392453

Upper Limb Robotic Rehabilitation During COVID-19 Outbreak

The COVID-19 outbreak requires a rapid re-shaping of the entire organization of the rehabilitation services. This includes the design and planning of appropriate rehabilitation settings, intervention and logistics for organizing space for patients.

The aims of this study are: (a) to evaluate the feasibility of the bedside use of a novel rehabilitation device for upper limb in patients with stroke; (b) to evaluate the motor and cognitive outcomes of the treatment; (c) to validate the instrumental outcomes provided by the device.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fondazione Don Carlo Gnocchi

Rome, 00168, Italy

About this study

This study aims to:

  • evaluate the feasibility of the bedside use of a novel portable rehabilitation device for upper limb in patients with stroke in an inpatient setting;
  • assess motor and cognitive outcomes of the treatment;
  • validate the instrumental outcomes provided by the device.

Forty subacute stroke patients with upper limb hemiplegia will be enrolled. Patients' upper limb will be treated with a novel portable robotic device (Icone, Heaxel). The robot will be transferred to each patient's room, where the rehabilitation session will be performed, thanks to the portability of the device. During the treatment, patients will execute "exergames" involving elbow flexion-extension, shoulder protraction-retraction, internal-external rotation, flexion-extension and abduction-adduction. The exercises will be selected among the available ones to train both motor and cognitive functions. The rehabilitation intervention will include 30 rehabilitation sessions, each lasting 45 minutes, three to five times a week. In addition to the upper limb treatment, patients will receive a rehabilitation treatment for the lower limbs.

For Aim 1, the usability and the acceptability of the device and the satisfaction with the treatment will be evaluated at the end of the rehabilitation intervention by means of the System Usability Scale (SUS), the Technology Acceptance Model (TAM), and the Likert scale, respectively.

For Aim 2, the clinical effect of the treatment with the robot will be investigated by means of the following scales, assessed both at baseline and at discharge: the Fugl-Meyer Assessment for the upper extremity (FMA-UE), the Motricity Index (MI), the Modified Ashworth Scale (MAS), the Modified Barthel Index (mBI), the Numeric Pain Rating Scale (NPRS), and the Montreal Cognitive Assessment (MoCA)

For Aim 3, at baseline, each patient will perform the kinematic and kinetic assessment provided by the robot twice, one day apart, to assess the reliability of the kinematic parameters provided by the robot; moreover, the kinematic and kinetics assessment will be performed every ten rehabilitation sessions, to analyze the responsiveness of the kinematic parameters and possible "plateau" in the recovery process.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • first ischemic or hemorrhagic stroke (verified by MRI or CT);
  • time latency within 6 months from stroke (subacute patients);
  • age between 35-85 years;
  • cognitive abilities adequate to understand the experiments and the follow instructions
  • upper limb impairment (FMA-UE score ≤58);
  • ability to give written consent;
  • compliance with the study procedures.

Exclusion criteria

  • history of recurrent stroke;
  • inability to understand the instructions required for the study;
  • fixed contractions in the affected limb (ankylosis, Modified Ashworth Scale equal to 4);
  • severe deficits in visual acuity.

Treatment and study plan

Robotic therapy

Device

The treatment with the robot Icone will include 30 sessions, each session lasting 45 minutes, with a frequency from three to five times a week. The treatment will be provided in the patient's room. Patients will execute upper limb movement involving elbow flexion-extension, shoulder protraction-retraction, internal-external rotation, flexion-extension, and abduction-adduction. Visual and auditory feedback will be provided during the tasks. The exercises will train both motor and cognitive functions.

Primary outcomes

  1. System Usability Scale (SUS)

    Time frame: After 30 rehabilitation sessions

    It is a tool for measuring the usability

  2. Technology Acceptance Model (TAM)

    Time frame: After 30 rehabilitation sessions

    It is a tool for measuring the acceptability.

  3. Likert Scale

    Time frame: After 30 rehabilitation sessions

    It is a tool for measuring the satisfaction.

Secondary outcomes

  1. Fugl-Meyer Assessment for upper extremity (FMA-UE)

    Time frame: At baseline; after 30 rehabilitation sessions

    The Fugl-Meyer Assessment is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment.

  2. Motricity Index for the upper extremity (MI-UE)

    Time frame: At baseline; after 30 rehabilitation sessions

    It is a clinical instrument for characterizing the strength of the paretic upper extremity following stroke.

  3. Modified Ashworth Scale (MAS)

    Time frame: At baseline; after 30 session rehabilitation sessions

    It is a clinical instrument for characterizing upper limb spasticity. Shoulder, elbow and wrist spasticity will be assessed.

  4. Numeric Pain Rating Scale (NPRS)

    Time frame: At baseline; after 30 rehabilitation sessions

    It is a unidimensional measure of pain intensity in adults.

  5. Modified Barthel Index (mBI)

    Time frame: At baseline; after 30 rehabilitation sessions

    It is a measure of independence in activities of daily living.

  6. Montreal Cognitive Assessment (MoCA)

    Time frame: At baseline; after 30 rehabilitation sessions

    It is a widely used screening assessment for detecting cognitive impairment.

  7. Kinematic parameters

    Time frame: At baseline (twice, one day apart); after 10 rehabilitation sessions; after 20 rehabilitation sessions; after 30 rehabilitation sessions

    The kinematics of the end-effector of the robot will be acquired during point-to-point tasks.

Sponsors and collaborators

Lead sponsor

Fondazione Don Carlo Gnocchi ETS

Other

Registry information

Official study title

Upper Limb Robotic Rehabilitation in Stroke Survivors Using a Portable Device During the COVID-19 Outbreak. A Feasibility Study

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 18, 2020
Registry last updated
Feb 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.